Paper Details

  1. Home
  2. Paper Details

Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.

Author: CarrellDavid, CoreyLawrence, KexelElizabeth, RemingtonMichael, WaldAnna, ZehJudy

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

A 2-day course of acyclovir was found to be effective in treating recurrent genital herpes, significantly reducing the duration of lesions, episodes, and viral shedding compared to a placebo. It also increased the proportion of aborted episodes.
Paper Details　
Original Abstract of the Article :
The standard course of antiviral therapy for recurrent genital herpes requires administration of multiple doses of medication for 5 days. To assess the efficacy of a shorter course of antiviral therapy, patients with recurrent genital herpes simplex virus type 2 (HSV-2) infection were enrolled in a ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1086/339325

データ提供：米国国立医学図書館（NLM）

A Short and Sweet Approach to Recurrent Genital Herpes

This research explores the effectiveness of a shorter course of antiviral therapy for recurrent genital herpes simplex virus type 2 (HSV-2) infection. The study found that a two-day regimen of acyclovir (800 mg three times a day) was significantly effective in reducing the duration of lesions, viral shedding, and the overall episode. This research provides valuable insights into the potential of a shorter treatment course for recurrent genital herpes.

Acyclovir: A Two-Day Cure for Recurrent Genital Herpes?

This research suggests that a shorter course of antiviral therapy may be just as effective as the standard five-day regimen for treating recurrent genital herpes. The study found that a two-day regimen of acyclovir significantly reduced the duration of lesions, viral shedding, and the overall episode, indicating that a shorter treatment course may be sufficient for managing this common condition. This research opens the door for a more convenient and potentially less burdensome treatment approach for patients.

Simplifying Treatment for Recurrent Genital Herpes

This research highlights the importance of finding less burdensome and more convenient treatment options for recurrent genital herpes. The study suggests that a two-day regimen of acyclovir may be a viable alternative to the standard five-day course, offering patients a simpler and potentially more comfortable treatment experience. Just as a camel finds a shortcut through the desert, this research paves the way for a more efficient and effective treatment approach for this common condition.

Dr.Camel's Conclusion

This study reminds us that even seemingly simple changes, such as a shorter treatment course, can have a significant impact on the lives of patients. The findings suggest that a two-day regimen of acyclovir is a viable alternative for treating recurrent genital herpes, offering a more convenient and potentially less burdensome treatment experience. Just like a camel finding a hidden oasis, this research offers a refreshing perspective on managing this common condition.

Date :
  1. Date Completed 2002-03-19
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

11880960

DOI: Digital Object Identifier

10.1086/339325

Related Literature

Article Analysis
・Effective treatment of genital herpes
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.